⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

April 9, 2024Neurology

Improved Neuromuscular Junction in R98C Mpz Heterozygous Mice Treated with IFB-088 (S21.010)

Yunhong Bai David Wang Xingyao Wu Mason M. LaMarche Michael E. Shy

View Full Paper

Ask AI

Bookmark

Share

Abstract

To evaluate neuromuscular junctions (NMJ) in R98C Mpz mutant mice treated with IFB088, a specific inhibitor of Gadd34/Ppp1r15a phosphatase

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Bai et al. (2024) studied this question.

synapsesocial.com/papers/68e6fcc5b6db6435876774b9 https://doi.org/10.1212/wnl.0000000000204928

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Treatment with IFB-088 Improves Neuropathy in CMT1A and CMT1B MiceOriginal Research · 2022 · 44 citations
2Treatment with IFB-088 improves neuropathy in CMT1A and CMT1B miceOriginal Research · 2021 · 3 citations
3Structural and functional alterations of neuromuscular synapses in a mouse model of ACTA1 congenital myopathypreclinical · 2022 · 1 citations
4The perijunctional zone is a molecularly distinct muscle subdomain altered in Duchenne muscular dystrophypreclinical · 2026 · 1 citations
5Two new mouse models of Gjb1 ‐associated Charcot–Marie–Tooth disease type 1XOriginal Research · 2023 · 8 citations